Renal injury and salt-sensitive hypertension after exposure to catecholamines

Hypertension

Volumn 34, Issue 1, 1999, Pages 151-159

  Johnson, Richard J ^a   Gordon, Katherine L ^a   Suga, Shinichi ^a   Duijvestijn, Adrian M ^d   Griffin, Karen ^b,c   Bidani, Anil ^b,c  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c Surgical Services Edward Hines Veterans Affairs Hospital   (United States)

^d NONE

Author keywords

Hypertension, episodic; Phenylephrine; Renal circulation; Sympathetic nervous system

Indexed keywords

MESSENGER RNA; OSTEOPONTIN; PHENYLEPHRINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; HYPERTENSION; KIDNEY FIBROSIS; MACROPHAGE; MYOFIBROBLAST; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SALT INTAKE; SYSTOLIC BLOOD PRESSURE;

EID: 0032791730     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.1.151     Document Type: Article

References (44)

1. Julius S, Nesbitt S. Sympathetic overactivity in hypertension: a moving target. Am J Hypertens. 1996;9:113S-120S.
2. Mancia G. Björn Folkow Award Lecture: the sympathetic nervous system in hypertension. J Hypertens. 1997;15:1553-1565.
3. deBlois D, Schwartz SM, van Kleef EM, Su JE, Griffin KA, Bidani AK, Daemen M, Lombardi DM. Chronic α1-adrenoreceptor stimulation increases DNA synthesis in rat arterial wall. Arterioscler Thromb Vasc Biol. 1996;16:1122-1129.
4. Blaes N, Boissel JP. Growth stimulating effect of catecholamines on rat aortic smooth muscle cells in culture. J Cell Physiol. 1983;116:167-172.
5. Meyers BD, Deen WM, Brenner BM. Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res. 1975;37:101-110.
6. Ferris TF, Gorden P. Effect of angiotensin and norepinephrine upon urate clearance in man. Am J Med. 1968;44:359-365.
7. Hoogenberg K, Sluiter WJ, Nais G, Van Haeften TW, Smit AJ, Reitsma WD, Dullart WPF. Exogenous norepinephrine induces an enhanced microproteinuric response in microalbuminuric insulin-dependent diabetes mellitus. J Am Soc Nephrol. 1998;9:643-654.
8. Cowley A, Lohmeier TE. Changes in renal vascular sensitivity and arterial pressure associated with sodium intake during long-term intrarenal norepinephrine infusion in dogs. Hypertension. 1979;1: 549-558.
9. Cronin RE, Erickson AM, Torrence AL, McDonald KM, Schrier RW. Norepinephrine-induced acute renal failure: a reversible ischemic model of acute renal failure. Kidney Int. 1978;14:187-191.
10. Kleinjans J, Kasbergen C, Vervoort-Peters L, Smits J, Struyker Boudier HAJ. Chronic intravenous infusion of noradrenaline produces labile hypertension in conscious rats. Life Sci. 1981;29:509-514.
11. Beevers DG, Lip GYH. Does non-malignant essential hypertension cause renal damage? A clinician's view. J Hum Hypertens. 1996;10:695-699.
12. Freedman BI, Iskandar SS Appel RG. The link between hypertension and nephrosclerosis. Am J Kidney Dis. 1995;25:207-221.
13. Bidani AK, Griffin KA, Picken M, Lansky DM. Continuous telemetric blood pressure monitoring and glomerular injury in the remnant kidney model. Am J Physiol. 1993;34:F391-F398.
14. Thomas SE, Anderson S, Gordon KL, Oyama TT, Shankland SJ, Johnson RJ. Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J Am Soc Nephrol. 1998;9:231-242.
15. Iruela-Arispe L, Gordon K, Hugo C, Duijvestijn AM, Claffey KP, Reilly M, Couser WG, Alpers CE, Johnson RJ. Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol. 1995;147:1715-1727.
16. O'Brien KD, Gordon D, Deer S, Ferguson M, Chait A. Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J Clin Invest. 1992;89:1544-1550.
17. Pichler R, Giachelli CM, Lombardi D, Pippin J, Gordon K, Alpers CE, Schwartz SM, Johnson RJ. Tubulointerstitial disease in glomerulonephritis: potential role of osteopontin (uropontin). Am J Pathol. 1994;144: 915-926.
18. Thomas SE, Lombardi DM, Giachelli, Bohle A, Johnson RJ. Osteopontin expression, tubulointerstitial disease and essential hypertension. Am J Hypertens. 1998;11:954-961.
19. Lombardi DM, Gordon KL, Polinsky P, Suga S, Schwartz SM, Johnson RJ. Salt-sensitive hypertension develops after short-term exposure to angiotensin II. Hypertension. 1999;33:1013-1019.
20. Eng E, Veniant M, Floege J, Fingerle J, Alpers CE, Menard J, Clozel J-P, Johnson RJ. Renal proliferation and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension. Am J Hypertens. 1994;7: 177-185.
21. Stenström G, Ernest I, Tisell L-E. Long-term results in 64 patients operated upon for pheocnromocytoma. Acta Med Scand. 1988;223: 345-352.
22. Pruszczyk P, Januszewicz W, Feltynowski T, Chodakowska J, Wocial B, Pachocki R, Nielubowica J, Szostek M. Long term follow-up after surgical removal of pheochromocytoma: observations in 61 patients. Clin Exp Hypertens Theory Pract. 1991;A13:1179-1194.
23. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM. Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992;19:464-474.
24. Pichler R, Franceshcini N, Young BA, Hugo C, Andoh TF, Burdmann EA, Shankland S, Alpers CE, Bennett WM, Couser WG, Johnson RJ. Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol. 1995;6:1186-1196.
25. Navar LG. Renal autoregulation: perspectives from whole kidney and single nephron studies. Am J Physiol. 1978;234:F357-F370.
26. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 1992;90:278-281.
27. DiBona G, Kopp U. Neural control of renal function. Physiol Rev. 1997;77:75-197.
28. Hwang SM, Lopez CA, Heck DE, Gardner CR, Laskin DC, Denhardt DT. Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem. 1994;269:711-715.
29. Johnson RJ, Schreiner G. Hypothesis: the role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension. Kidney Int. 1997;52:1169-1179.
30. Wilcox CS, Baylis C. Glomerular-tubular balance and proximal regulation. In: Seldin DW, Giebisch G, eds. The Kidney: Physiology and Pathophysiology. New York, NY: Raven Press; 1985:985-1012.
31. Ekelund L-G, Suchindran CM, Karon JM, McMahon RP, Tyroler JA. Black-white differences in exercise blood pressure. Circulation. 1990;31: 1568-1574.
32. Dimsdale JER, Graham RM, Ziegler MG, Zusman RM, Berry CC. Age, race, diagnosis and sodium effects on the pressor response to infused norepinephrine. Hypertension. 1987;10:564-569.
33. Anderson NB, Lane JD, Muranaka M, Williams RB, Houseworth SJ. Racial differences in blood pressure and forearm vascular responses to the cold face stimulus. Psychosom Med. 1988;50:57-63.
34. Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk KA, Glassock R, for the AASK Pilot Study Investigators. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) trial. Kidney Int. 1997;51:244-252.
35. Sowers JR, Whitfield LA, Catania RA, Stern K, Tuck ML, Dornfeld L, Maxwell N. Role of the sympathetic nervous system in blood pressure maintenance in obesity. J Clin Endocrinol Metab. 1982;54:1181-1186.
36. Kasiske B, Crosson JT. Renal disease in patients with massive obesity. Arch Intern Med. 1986;146:1105-1109.
37. Bevan AT, Honour AJ, Stott FH. Direct arterial pressure recording in unrestricted man. Clin Sci. 1969;36:329-344.
38. Guyton AC, Coleman TG, Cowley AV, Scheell KW, Manning RD, Norman RA. Arterial pressure regulation: overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med. 1972; 52:584-594.
39. Lindeman RD, Goldman R. Anatomic and physiologic age changes in the kidney. Exp Gerontol. 1986;21:379-406.
40. Lindeman RD, Tobin JD, Shock NW. Association between blood pressure and the rate of decline in renal function with age. Kidney Int. 1984;26:861-868.
41. Bidlingmeyer I, Burnier M, Bidlingmeyer M, Waeber M, Brunner HR. Isolated office hypertension: a prehypertensive state? J Hypertens. 1996; 14:327-332.
42. Leßke J, Fletcher E, Bao G, Unger T. Hypertension caused by chronic intermittent hypoxia-influence of chemoreceptors and sympathetic nervous system. J Hypertens. 1997;15:1593-1603.
43. Wilson, NV, BM Meyer. Early prediction of hypertension using exercise blood pressure. Prev Med. 1981;10:62-68.
44. Mackenzie HE, Lawler J, Brenner BM. Pathogenesis and pathophysiology of essential hypertension: congenital oligonephropathy: the fetal flaw in essential hypertension? Kidney Int. 1996;49:S30-S34.